Cargando…
Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial
Adolescent girls and young women (AGYW) in sub-Saharan Africa may benefit from pre-exposure prophylaxis (PrEP), yet stigma may limit PrEP acceptance and continuation. We examined factors associated with PrEP use stigma among 307 participants of the EMPOWER trial (2016–2018), an unblinded randomized...
Autores principales: | Munthali, R. J., Stangl, A. L., Baron, D., Barré, I., Harvey, S., Ramskin, L., Colombini, M., Naicker, N., Kapiga, S., Delany-Moretlwe, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640431/ https://www.ncbi.nlm.nih.gov/pubmed/35776254 http://dx.doi.org/10.1007/s10461-022-03721-6 |
Ejemplares similares
-
PrEP implementation research in Africa: what is new?
por: Cowan, Frances M, et al.
Publicado: (2016) -
Understanding the Association between PrEP Stigma and PrEP Cascade Moderated by the Intensity of HIV Testing
por: Zhang, Chen, et al.
Publicado: (2022) -
Exploring the feasibility and acceptability of integrating screening for gender-based violence into HIV counselling and testing for adolescent girls and young women in Tanzania and South Africa
por: Colombini, Manuela, et al.
Publicado: (2021) -
Response to “Oral PrEP for young African women and men”
por: Celum, Connie L, et al.
Publicado: (2016) -
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
por: Donnell, Deborah, et al.
Publicado: (2023)